Nouryon has signed an agreement with Renewcell to provide specialty chemicals and engineering solutions for its new textile recycling plant in Sundsvall, Sweden. The facility will recycle textile waste, including items such as worn-out jeans and production scraps, to manufacture 60,000 metric tons of Circulose® dissolving pulp per year.
DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased reliability and greater sustainability.
Univar Solutions Inc., a global chemical and ingredient distributor and provider of value-added services, and Novozymes, the world leader in biological solutions, signed a new agreement to expand the partnership into the United States and Canadian food ingredients markets. The new food ingredients agreement takes effect May 1, one month after the companies announced an exclusive agreement expanding the partnership into the United States and Canadian beverage production, homecare, and industrial cleaning markets.
Innovative sugar beet processor Cosun Beet Company, part of Royal Cosun, and Avantium N.V., a leading technology company in renewable chemistry, will jointly construct and operate the first commercial plant for the production of plant-based glycols using Avantium’s Ray TechnologyTM. To this end, Cosun Beet Company and Avantium entered into a Term Sheet to establish a joint venture in which Cosun Beet Company will take a substantial share.
Clariant, a focused, sustainable, and innovative specialty chemical company, is working with Indonesia’s state-owned oil and gas corporation, Pertamina, since 2018 to evaluate and test the feasibility of Clariant’s sunliquid®technology to process available regional feedstocks in Indonesia into the advanced biofuel, cellulosic ethanol.
Amyris, a leading synthetic biotechnology company headquartered in the United States of America, executed a binding term sheet for the acquisition of Gen Z-focused beauty brand, EcoFabulous Cosmetics. The acquisition furthers Amyris’s growth and market leadership in clean beauty and complements Amyris’s family of consumer brands, consisting of Biossance®, Pipette®, Rose Inc., JVN, Terasana, and Costa Brazil.
UPM Plywood, Arctic Astronautics and Huld are ready to launch the first ever wooden satellite, WISA WOODSATTM, into Earth’s orbit by the end of 2021.
WISA Woodsat will go where no wood has gone before. With a mission to gather data on the behavior and durability of plywood over an extended period in the harsh temperatures, vacuum and radiation of space in order to assess the use of wood materials in space structures.
“I think the overall policy framework is clear about the strategic role of bio-based industries in achieving the EU sustainability objectives. There is also clarity about the direction of EU support in the coming decade.” Philippe Mengal, executive director of the Bio-based Industries Joint Undertaking talks to Il Bioeconomista.
European oil giant Shell joined as an investor in LanzaJet to advance the Illinois-based company’s global growth, accelerate commercialization of its technology, and scale the production of Sustainable Aviation Fuel (SAF). Shell joined founding investors in LanzaJet, including LanzaTech, Suncor Energy Inc., Mitsui & Co., Ltd., and more recently, British Airways, as well as participation from All Nippon Airways. In addition to its initial investment in LanzaJet and similar to the phased investment approach used with all of the LanzaJet investors, Shell will have the opportunity to make further investments in the construction of larger-scale production facilities over the coming years.
“Simplification of the European regulatory framework could also go a long way toward accelerating and promoting the circular bioeconomy surge.“ Nicolas Sordet, founder and CEO of AFYREN, talks to Il Bioeconomista. Founded in 2012 and headquartered in France, AFYREN collected more than €70 million funding in 2019, which allows the company to grow from a pilot stage to industrial-scale production.